Loading clinical trials...
Loading clinical trials...
A Multi-center,Double-blind,Randomized,Three-arm,Placebo-controlled,Parallel-group Study, Comparing Dapsone Gel,7.5% (Torrent Pharma) to Aczone® Gel,7.5% and Both Active Treatments to a Placebo Control in the Treatment of Acne Vulgaris
Conditions
Interventions
Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)
ACZONE® (dapsone) gel, 7.5% (Allergan, INC.)
+1 more
Locations
13
United States
Unison Center for Clinical Trials
Sherman Oaks, California, United States
MOORE Clinical Research, Inc.
Brandon, Florida, United States
FXM Clinical Research Miami
Miami, Florida, United States
FXM Clinical Research Miramar
Miramar, Florida, United States
MOORE Clinical Research, Inc. (S. Tampa Site)
Tampa, Florida, United States
MOORE Clinical Research, Inc. (Temple Terrace Site)
Temple Terrace, Florida, United States
Start Date
July 11, 2019
Primary Completion Date
February 3, 2020
Completion Date
February 22, 2020
Last Updated
April 2, 2020
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Torrent Pharmaceuticals Limited
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions